CONAZ

This brand name is authorized in Nigeria.

Active ingredients

The drug CONAZ contains one active pharmaceutical ingredient (API):

1	Ketoconazole UNII R9400W927I - KETOCONAZOLE
	Ketoconazole is an imidazole-dioxolane antimycotic, active against yeasts, including Malassezia and dermatophytes.
	Read more about Ketoconazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-1285	Cream	Conaz Cream CREAM 2% 1 x 20 g (in Alu tube)	Cream A white semi-solid cream with a smooth texture Conaz Cream A11-1285 Conaz KETOCONAZOLE ANTIFUNGAL KETOCONAZOLE 2% CREAM X 20G PRESCRIPTION ONLY MEDICINE USED IN THE TREATMENT OF FUNGAL INFECTIONS INCLUDING BLASTOMYCOSIS, CANDIDIASIS JAWA INTERNATIONAL LIMITED NIGERIA JAWA INTERNATIONAL LIMITED NIGERIA 08/25/2022 08/24/2027	25/08/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D01AC08	Ketoconazole	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-1285